Document is current
Any future updates will be listed below
-
Authors
Williamson, Samantha J.
Liebau, Max
Lennon, R.Rachel
- License Information
-
More Information
Article History
Received: 4 February 2025
Revised: 4 February 2025
Accepted: 5 February 2025
First Online: 16 April 2025
Declarations
:
: RL is a consultant for Travere Therapeutics, Calliditas Therapeutics and receives research funding from FourPoints Innovation and Novo Nordisk. The other authors have nothing to declare.
